建立嵌合体诱导器官移植免疫耐受的研究进展
被引量：1
摘要
建立器官移植免疫耐受是维持移植器官长期存活的理想境界。其中建立嵌合体是诱导器官免疫耐受的重要途径。本文就建立嵌合体的种类、方法、途径及其诱导免疫耐受的机理的研究进展作一综述。
出处
《国外医学（泌尿系统分册）》
2005年第6期739-742,共4页
Foreign Medical Sciences(Urology and Nephrology Foreign Medical Sciences)
参考文献26
-
1Matthews JB, Ramos E, Bluestone JA. Clinical trials of transplant tolerance: slowbut steady progress. Am J Transplant,2003,3:794-803.
-
2Ito H,KurtzJ,ShafferJ,etal. CD4 T cell-mediated alloresistance to fully MHC - mismatched allogeneic bone marrow engraftment is dependent on CD40 - CD40 ligand interactions, and lasting T cell tolerance is induced by bone marrow transplantation with initial blockade of this pathway. J Immunol,2001,166:2970 - 2981.
-
3Takeuchi Y, Ito H, Kurtz J, et al. Earlier low - dose TBI or DST overcomes CD8 + T - cell - mediated alloresistance to allogeneic marrow in recipients of anti - CD40L. Am J Transplant,2004,4:31-40.
-
4Seung E, Mordes JP, Rossini AA, et al. Hematopoietic chimerism and central tolerance created by peripheral - tolerance induction without myeloablative conditioning. J Clin Invest,2003,112:795-808.
-
5Adams AB,Pearson TC,Larsen CP. Hcterologous immunity:an overlooked barrier to tolerance. Immunol Rev,2003,196:147 - 160.
-
6Adams AB, Williams MA, Jones TR, et al. Heterologous imounity provides a potent barrier to transplantation tolerance. J Clin Invest,2003, 111:1887-1895.
-
7Rifle G, Mousson C. Donor - derived hematopoictic cells in organ transplantation: a major step toward allograft tolerance? Transplantation,2003,75:3S - 7S.
-
8Monaco AP. Prospects and strategies for clinical tolerance. Transplant Proc, 2004,36:227 - 231.
-
9Gleit ZL, Fuchimoto Y, Yamada K, et al. Variable relationship between chimerism and tolerance after hematopoietic cell transplantation without myelosuppressive conditioning. Transplantation, 2002,74:1535 - 1544.
-
10Starzl TE, Murase N,Abu-Elmagd K, et al. Tolerogenic immunosuppression for organ transplantation. Lancet,2003,361:1502-1510.
同被引文献15
-
1刘小村,刘小群,张百萌.同种异体器官移植免疫耐受的机理研究进展[J].中国误诊学杂志,2004,4(7):1013-1016. 被引量：3
-
2王晓亮,彭民浩.CTLA4-Ig与器官移植免疫耐受的诱导[J].国外医学（外科学分册）,2005,32(3):214-217. 被引量：1
-
3钟鑫平,赵国华,刘永锋.联合阻断CD28/B7和ICOS对大鼠肝移植免疫耐受的实验研究[J].陕西医学杂志,2006,35(10):1248-1250. 被引量：3
-
4郑德华,石炳毅.树突状细胞:诱导移植免疫耐受的工具细胞和靶细胞[J].解放军医学杂志,2006,31(12):1207-1208. 被引量：2
-
5Lkebukuro K,Adaehi Yamada Y,Fujimoto S. Treatment of strep to zotocin induced diabetes mellitus by transplantation of islet cells plid bone marrow cells via portal vein in rats [J]. Transplantation, 2002,73 (4) :512-518.
-
6Gauer L K,Kennedy E,Nitta Y. Induction of donorspecific tolerance to islet allografts in nonhuman primates[J]. Ann NY Acad Sci,2002,958..194-198.
-
7Jerzak M,Bischof P. Apoptosis in the first trimester human placenta: the role in maintaining immune privilege at the maternal-foetal interface and in the trophoblast remodelling[J]. Eur J Obstet Gynecol Reprod Biol,2002,100(2):138-142.
-
8Carroll H P,All S,Kirby J A. Accelerating the induction of Fas mediated T cell apoptosis:flstrategy for transplant tolerance[J]. Clin Exp Immunol, 2001,126 (3) :589-597.
-
9Sato K,Yamashita N ,Baba M,et al. Regulatory dendritic cells protect mice from murine acute graft-versus-host disease an d leukemia relapse [J]. Immunity, 2003,18 : 367-375.
-
10Peche H,Trinite B,Martinet B,et al. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone filarrow progenitors[J]. Am J Transplant, 2005,5: 255-259.
-
1刘忠国,温端改.肾脏移植诱导免疫耐受的基础与临床研究进展[J].国际泌尿系统杂志,2006,26(4):452-457.
-
2孙治君.诱导器官移植免疫耐受研究进展[J].重庆医科大学学报,2000,25(3):330-333.
-
3王绕绕,宋红丽.自噬在器官移植免疫耐受研究中的进展[J].实用器官移植电子杂志,2016,4(1):57-60. 被引量：7
-
4叶晟.器官移植免疫耐受研究概况[J].免疫学杂志,2001,17(z1):87-90. 被引量：2
-
5梁洪波.复杂性肾结石的临床治疗[J].中国当代医药,2009,16(9):180-180. 被引量：1
-
6梁洪波.复杂性肾结石的临床治疗[J].中国医学创新,2009,6(17):77-77. 被引量：5
-
7潘铁军,向军,饶作祥,杨家荣.复杂性肾结石开放性手术后残石的延期微创治疗[J].临床泌尿外科杂志,2003,18(4):210-211. 被引量：4
-
8姜睿.特异性供体骨髓输注诱导器官移植免疫耐受的现状[J].国外医学（泌尿系统分册）,2003,23(1):7-10. 被引量：2
-
9钟凤林,张彤,雷春,庄景盛,周洋.拇指再造5例报告[J].攀枝花医药,2001,23(B09):27-28.
-
10王晓亮,彭民浩.CTLA4-Ig与器官移植免疫耐受的诱导[J].国外医学（外科学分册）,2005,32(3):214-217. 被引量：1
